Efficacy and Safety of Lasmiditan in Patients Using Concomitant Migraine Preventive Medications: Findings From SAMURAI and SPARTAN, Two Randomized Phase 3 Trials

Journal of Headache and Pain - Italy
doi 10.1186/s10194-019-1032-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

Headache
Neurology
2019English

Efficacy, Safety, and Tolerability of Brivaracetam With Concomitant Lamotrigine or Concomitant Topiramate in Pooled Phase III Randomized, Double-Blind Trials: A Post-Hoc Analysis

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2018English

Exposure‐Response Relationships for Efficacy and Safety of Risankizumab in Phase 2 and 3 Trials in Psoriasis Patients

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Efficacy and Safety of Sodium Zirconium Cyclosilicate in Patients With Baseline Serum Potassium Level ≥ 5.5 Mmol/L: Pooled Analysis From Two Phase 3 Trials

BMC Nephrology
Nephrology
2019English

Testing Cardiovascular Drug Safety and Efficacy in Randomized Trials

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2014English

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies

Headache
Neurology
2019English

Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients With Migraine: Results From Two Global Phase 3 Clinical Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials

Journal of the American Academy of Dermatology
Dermatology
2018English

Pnd67 - Are New Preventive Migraine Drugs Cost-Effective for Patients With Chronic and Episodic Migraine for Whom Other Preventive Medications Had Failed?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy